REGN | Regeneron Pharmaceuticals
Category: Biotechnology company
Quick infos Headquarters: Tarrytown, New York, United States Trade prices Volume: 1.3M Market Cap: 65.4B Prev closed: 609.17 Open: 612.1 High: 630.76 Low: 608.76 52 week low: 271.37 52 week high: 646.33 Dividends: No Dividends Next ER: August 3, 2022 Before Market Opens
About the Company Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988.
Earnings History Date EPS / Forecast Revenue / Forecast November 8, 2022 August 3, 2022 9.77 / 8.62.86B / 2.79BBeat! May 4, 2022 11.49 / 9.722.97B / 2.69BBeat! February 4, 2022 23.72 / 20.44.95B / 4.56BBeat! November 4, 2021 15.37 / 10.363.45B / 2.75BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 648.70 643.49 649.77
639.70
602.89K 0.84% Aug 15, 2022 643.29 628.70 643.60
624.80
539.21K 2.32% Aug 12, 2022 628.71 628.87 632.57
622.30
351.28K 0.77% Aug 11, 2022 623.90 638.63 643.98
622.37
468.06K -2.74% Aug 10, 2022 641.49 630.00 645.95
624.78
681.69K 3.11% Aug 9, 2022 622.15 630.00 634.85
617.10
469.54K -1.34% Aug 8, 2022 630.63 619.78 633.93
618.87
715.23K 2.77% Aug 5, 2022 613.61 613.47 621.63
606.96
566.77K -0.22% Aug 4, 2022 614.96 602.65 623.35
602.65
695.07K 1.02% Aug 3, 2022 608.77 600.00 623.48
595.16
1.15M 5.88% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US75886F1075 CUSIP: 75886F107 Founded:1988 Employees:5,400 News
Regeneron Announces Investor Conference Presentations finance.yahoo.com Jan 23, 2023 4:05 pm
Regeneron accelerates research spending as drug pipeline grows bizjournals.com Jan 23, 2023 3:05 pm U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents finance.yahoo.com Jan 23, 2023 2:09 pm UPDATE 2-U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents finance.yahoo.com Jan 23, 2023 2:08 pm RPT-U.S. Supreme Court to hear Amgen bid to revive Repatha patents finance.yahoo.com Jan 23, 2023 1:40 pm
Intellia's (NTLA) Q3 Loss Wider Than Expected, Revenues Up Y/Y finance.yahoo.com Jan 23, 2023 12:18 pm
Regeneron (REGN) Q3 Earnings & Sales Beat on Eylea, Dupixent finance.yahoo.com Jan 23, 2023 11:43 am
Regeneron (REGN) Gets FDA Nod for Libtayo's Label Expansion finance.yahoo.com Jan 23, 2023 10:43 am
Regeneron Presents New Data at ASH from Advancing Hematology Pipeline across Multiple Blood Cancers and Disorders finance.yahoo.com Jan 23, 2023 9:00 am
Regeneron Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations finance.yahoo.com Jan 23, 2023 7:42 am Regeneron Pharmaceuticals Q3 tops earnings and revenue marks marketwatch.com Jan 23, 2023 6:51 am
Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis finance.yahoo.com Jan 20, 2023 1:53 pm
What's in Store for Regeneron Pharmaceuticals (REGN) in 2023? finance.yahoo.com Jan 20, 2023 12:13 pm
Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More finance.yahoo.com Jan 20, 2023 11:10 am Will This Potential Approval Be a Winner for Sanofi's Shareholders? fool.com Jan 20, 2023 10:23 am 2 Market-Beating Stocks That Can Continue Rising in 2023 fool.com Jan 20, 2023 5:35 am
Healthcare Stocks See Winners and Losers on Monday finance.yahoo.com Jan 20, 2023 10:45 am
Linvoseltamab (BCMAxCD3) Initial Pivotal Phase 2 Data Show Clinically Meaningful Responses in Patients with Heavily Pre-treated Multiple Myeloma finance.yahoo.com Jan 20, 2023 10:00 am
Regeneron Reveals An Early Cut Data From Follicular Lymphoma Study At ASH Meeting finance.yahoo.com Jan 20, 2023 8:31 am
Libtayo® (cemiplimab) Approved in Japan for Advanced or Recurrent Cervical Cancer finance.yahoo.com Jan 20, 2023 8:30 am This company doesn't provide a dividend.
Key Persons CEO : Leonard S. Schleifer, MD, PhD Talk about Regeneron Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
